Top Markets
#1 Derive Derive +30.46%
#2 Audiera Audiera +14.41%
#3 The Bitcoin Bull The Bitcoin Bull +10.64%
#4 Cross Cross +10.45%
#5 Geodnet Geodnet +9.21%
#6 Gama Token Gama Token +9.19%
#7 Palladium Network Palladium Network +7.97%
#8 Humanity Humanity +7.62%
#9 Cap Cap +7.48%
#10 Starpower Starpower +7.47%
Coin of the day
Derive Derive
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Kazia Therapeutics Limited Kazia Therapeutics Limited

Kazia Therapeutics Limited

KZA
Rangering i aksjer #35840
Kazia Therapeutics Limited is a biotechnology firm specializing in oncology,... Kazia Therapeutics Limited is a biotechnology firm specializing in oncology, committed to developing innovative therapies for cancer. Its flagship product candidate, Paxalisib, is a brain-penetrant small molecule that inhibits the PI3K/Akt/mTor pathway and is currently being investigated as a potential treatment for glioblastoma. Additionally, the company is progressing EVT801, an investigational new drug aimed at combating various types of cancer. Established in 1994 and headquartered in Sydney, Australia, the entity was formerly known as Novogen Limited before adopting the name Kazia Therapeutics Limited in November 2017.
Aksjekurs
$0.05207079
Sist synkronisert: 2023-11-15
Markedsverdi
$3.38M
Endring (1 dag)
0.13%
Endring (1 år)
0.00%
Land
AU
Handel Kazia Therapeutics Limited (KZA)

Kategori

Healthcare
Antall utestående aksjer for Kazia Therapeutics Limited (KZA)
Antall utestående aksjer per August 2026: 0
Ifølge Kazia Therapeutics Limited sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av August 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Kazia Therapeutics Limited (KZA) fra 2026 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
Ikke nok data for de angitte datoene.
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -
BE